PwC Partner Insights: Strategic Pathways for Pharma and MedTech Companies Under DRG/DIP Reforms

Facilitating the outflow of prescriptions;

Entering the commercial insurance sector;

Launch digital marketing...

The deepening of healthcare insurance system reforms continues to compel pharmaceutical and medical device companies to undergo transformational development.

Nowadays, the implementation of DRG/DIP payment reforms is accelerating from pilot programs to nationwide adoption. This transition will bring about significant changes in clinical practices, medication use, medical insurance reimbursement, and hospital operational management across healthcare institutions at all levels. Consequently, the entire lifecycle of pharmaceutical and medical device products—including market access, pricing, utilization, and payment—will continue to be profoundly influenced by these DRG/DIP payment reforms.

However, the transformation of pharmaceutical and medical device companies is by no means an overnight endeavor. This is because various novel market strategies are not universally applicable to every company; each must identify the breakthrough approach best suited to its own circumstances.

So, how can pharmaceutical and medical device companies identify the market strategy best suited to their needs? How can they turn challenges into opportunities? With these questions in mind,August 25, 2022, 20:00–21:30，VBSelectJoining HandsPwCCo-hosted"Strategies for Pharmaceutical and Medical Device Companies to Break Through Under DRG/DIP Payment Reforms"Live Online Public Lecture: Providing Strategic Decision-Making Insights and Recommendations for Pharmaceutical and Medical Device Companies.

For readers participating in this open course, we will additionally providePublic Course Preview Materials, Healthcare Enterprise Management Documents, In-Depth Industry ReportsWait for exclusive insights and perks,Scan the QR codes below to join the group and reserve your spot for the live stream.Available upon registration for the event.

Top 10Participants who sign up will also havePwC <Free Consultation Service> 2 HoursBenefit Package Unlocked! This benefit will be provided by senior industry consultants from PwC, for you1-on-1 Dedicated SupportConsulting services on corporate strategic planning, digital transformation planning, and more—limited spots available, first come, first served!

Senior Partner in the Healthcare and Life Sciences SectorWith over 18 years of experience, this senior partner specializes in ecosystem and industry chain planning, strategic planning, business and operational model design, top-level organizational and operational control architecture, and digital transformation within the broader healthcare industry, including health insurance, medical services, pharmaceuticals, medical devices, and elderly care. He/She has delivered numerous professional solutions to a diverse clientele, including Healthcare Security Administrations, private equity/venture capital (PE/VC) firms, pharmaceutical and medical device companies, and hospital groups.

PwC, one of the Big Four international accounting firms, maintains branches and offices in more than 150 countries and regions worldwide. It is committed to delivering high-quality services in audit, consulting, tax, and other fields to businesses and individuals, thereby meeting the needs of diverse clients across the globe.

1. How Can Pharmaceutical and Medical Device Companies Assess Market Demand Based on Their Position in the Value Chain?

2. How to Design Innovative Business Models?

3. How to Address the Challenge of Designing a Digital Transformation Roadmap?

1. Overview of Stakeholders Under DRG/DIP Payment Reform.

2. Digital Transformation of Pharmaceuticals and Medical Devices—What to Transform?

3. Digital Transformation of Pharmaceuticals and Medical Devices – How to Transform?

Founders and Partners of Pharmaceutical and Medical Device Companies

[Recommendation Level:★★★★★】

VP-Level Management of Pharmaceutical and Medical Device Companies

[Recommendation: ★★★★]

Director, Marketing Department and Strategic Development Department, Pharmaceutical and Medical Device Company

[Recommendation: ★★★]

If you belong to any of the above groups, be sure not to miss this information-packed open lecture.

“Artery Open Course” is one of the branded columns under VCBeat’s “VCBeat Select.” Centered on addressing development pain points and exploring systematic solutions in the healthcare sector, it leverages an online live-streaming platform for knowledge sharing and exchange. By continuously inviting seasoned industry practitioners and experts to collaboratively develop and deliver a series of themed courses, it aims to provide healthcare enterprises with in-depth, high-value practical insights. Artery Open Course: Making the selection of knowledge simpler.